Showing 11,981 - 12,000 results of 101,662 for search '(( 2 step decrease ) OR ( 5 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.55s Refine Results
  1. 11981
  2. 11982

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  3. 11983

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  4. 11984

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  5. 11985
  6. 11986
  7. 11987

    Image5.TIF by Lei Xu (78676)

    Published 2018
    “…Saliva was collected and oral examination was conducted at the beginning of this trial, and then every subsequent 6 months for a total of five time points (T0, T1, T2, T3, and T4). …”
  8. 11988
  9. 11989

    Image_5.TIF by Yumeng Shi (1351218)

    Published 2018
    “…</p>Results<p>Knockdown SOX5 decreased lamellipodium formation, migration, and invasion of RA-FLS. …”
  10. 11990

    Image_5.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…Selective blockade of CCR1 (Met-RANTES therapy) in infected Ccr5<sup>−/−</sup> mice supported a protective role for CCR1 in CCC. …”
  11. 11991

    Supplementary Material for: The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training by Pisani A. (10713897)

    Published 2021
    “…<b><i>Introduction:</i></b> The SARS-CoV-2 (COVID-19) pandemic has brought about a radical change in our working patterns. …”
  12. 11992

    (A) Experimental timeline and (B) results (mean ± SEM) in Experiment 1 on the effect of adaptation to a decrease and an increase in height of the ball drop. by Ana Tajadura-Jiménez (315994)

    Published 2018
    “…The diagonal line is a linear regression line (y = -1.135 x– 0.7133, R<sup>2</sup> = 0.9734) and illustrates a decrease in step size with increasing the simulated height of the ball drop during the audio-tactile adaptation. …”
  13. 11993
  14. 11994
  15. 11995
  16. 11996

    DataSheet_1_Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzhe... by Eleni Fella (3925409)

    Published 2022
    “…We have previously administered the modified C5a receptor agonist (EP67) for a short period to a transgenic mouse model of AD (5XFAD) and have observed not only reduction in β-amyloid deposition and gliosis but also improvement in cognitive impairment. …”
  17. 11997
  18. 11998
  19. 11999
  20. 12000